Log in

NASDAQ:STAA - STAAR Surgical Stock Price, Forecast & News

-0.02 (-0.06 %)
(As of 02/20/2020 05:15 AM ET)
Today's Range
Now: $35.99
50-Day Range
MA: $37.14
52-Week Range
Now: $35.99
Volume456,500 shs
Average Volume393,648 shs
Market Capitalization$1.60 billion
P/E Ratio199.96
Dividend YieldN/A
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. Read More…

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:STAA



Sales & Book Value

Annual Sales$123.95 million
Cash Flow$0.33 per share
Book Value$3.00 per share


Net Income$4.97 million


Market Cap$1.60 billion
Next Earnings Date2/26/2020 (Confirmed)

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) posted its quarterly earnings results on Wednesday, October, 30th. The medical instruments supplier reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. The medical instruments supplier earned $39.06 million during the quarter, compared to analysts' expectations of $37.50 million. STAAR Surgical had a return on equity of 13.84% and a net margin of 6.15%. View STAAR Surgical's Earnings History.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for STAAR Surgical.

How can I listen to STAAR Surgical's earnings call?

STAAR Surgical will be holding an earnings conference call on Wednesday, February 26th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $150.2-150.2 million, compared to the consensus revenue estimate of $149.45 million.

What price target have analysts set for STAA?

3 Wall Street analysts have issued 12-month target prices for STAAR Surgical's stock. Their forecasts range from $45.00 to $56.00. On average, they anticipate STAAR Surgical's share price to reach $49.00 in the next twelve months. This suggests a possible upside of 36.1% from the stock's current price. View Analyst Price Targets for STAAR Surgical.

What is the consensus analysts' recommendation for STAAR Surgical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.

Has STAAR Surgical been receiving favorable news coverage?

News articles about STAA stock have been trending extremely negative recently, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. STAAR Surgical earned a news impact score of -4.6 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for STAAR Surgical.

Are investors shorting STAAR Surgical?

STAAR Surgical saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 4,250,000 shares, an increase of 7.6% from the January 15th total of 3,950,000 shares. Based on an average daily trading volume, of 393,400 shares, the days-to-cover ratio is currently 10.8 days. Currently, 9.7% of the company's shares are short sold. View STAAR Surgical's Current Options Chain.

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 65)
  • Ms. Deborah J. Andrews, Chief Financial Officer (Age 62)
  • Dr. Keith Holliday, Chief Technology Officer (Age 56)
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 57)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations, Direct Markets- Europe & China (Age 54)

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Palo Alto Investors LP (8.48%), Baillie Gifford & Co. (4.36%), Capital International Investors (4.12%), State Street Corp (2.56%), Janus Henderson Group PLC (1.98%) and Defender Capital LLC. (1.35%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten, Scott D Barnes and William P Wall. View Institutional Ownership Trends for STAAR Surgical.

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Barclays PLC, Palo Alto Investors LP, State Street Corp, BosValen Asset Management Ltd, Principal Financial Group Inc., King Luther Capital Management Corp and Chicago Equity Partners LLC. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes. View Insider Buying and Selling for STAAR Surgical.

Which major investors are buying STAAR Surgical stock?

STAA stock was acquired by a variety of institutional investors in the last quarter, including Capital International Investors, Broadfin Capital LLC, Loomis Sayles & Co. L P, UBS Asset Management Americas Inc., Janus Henderson Group PLC, Royce & Associates LP, Bank of America Corp DE and Driehaus Capital Management LLC. View Insider Buying and Selling for STAAR Surgical.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $35.99.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $1.60 billion and generates $123.95 million in revenue each year. The medical instruments supplier earns $4.97 million in net income (profit) each year or $0.28 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.View Additional Information About STAAR Surgical.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is http://www.staar.com/.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]

MarketBeat Community Rating for STAAR Surgical (NASDAQ STAA)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  220 (Thanks for Voting!)
Underperform Votes:  303 (Thanks for Voting!)
Total Votes:  523
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe STAA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STAA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Featured Article: Nikkei 225 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel